InsiderPulse
Dashboard

ARVN

Arvinas, Inc.

Health CareRussell 2000

Arvinas, Inc. insider trading

Arvinas, Inc. files with the SEC as a Pharmaceutical Preparations company headquartered in New Haven, CT. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent ARVN insider transactions

7 insiders traded ARVN on the open market between Feb 23, 2026 and Jun 24, 2026 — 1 purchase worth $268.1K, 17 sales worth $1.2M, of which 2 were pre-scheduled under a 10b5-1 plan.

Bought
$268.1K
Sold
$1.2M

2 of 17 on a 10b5-1 plan

Net
−$903.1K
Insiders
7

Open-market purchases (code P) and sales (code S) from Arvinas, Inc.'s own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 23, 2026. The live dashboard shows new filings the moment they clear.

Every ARVN Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

ARVN insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 8 insiders traded ARVN on the open market: 2 purchases worth $495.1K and 34 sales worth $2.3M, 2 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 2 purchases ($495.1K) and 23 sales ($1.4M), by 7 insiders.

QuarterBoughtSold
Q2 2026—−$518.2K8 sales · 2 on a plan
Q1 2026+$268K1 buy−$900.8K14 sales
Q4 2025—−$2.3K1 sale
Q3 2025+$227.1K1 buy—
Q2 2025—−$62.7K2 sales
Q1 2025—−$839.6K8 sales
Q4 2024—−$6.4K1 sale
Q3 2024——
Largest purchase
+$268K of ARVN by Morrison Briggs (Director) on Mar 06, 2026.
Largest sale
−$438.6K of ARVN by Houston John G (President and CEO · Director) on Feb 24, 2025.

Open-market transactions through Jun 30, 2026most recent first

  • Saik Andrew10b5-1

    Chief Financial Officer

    −$46.5K

    Jun 24, 2026

    5,696 sh · $8.16

  • Cacace Angela M10b5-1

    Chief Scientific Officer

    −$19.6K

    Jun 17, 2026

    2,576 sh · $7.60

  • Teel Randy

    President and CEO · Director

    −$20K

    May 21, 2026

    2,209 sh · $9.04

  • Saik Andrew

    Chief Financial Officer

    −$110.7K

    May 11, 2026

    11,139 sh · $9.94

  • Berkowitz Noah

    Chief Medical Officer

    −$110.4K

    May 11, 2026

    11,108 sh · $9.94

  • Cacace Angela M

    Chief Scientific Officer

    −$96K

    May 11, 2026

    9,657 sh · $9.94

  • Teel Randy

    President and CEO · Director

    −$96K

    May 11, 2026

    9,657 sh · $9.94

  • Loomis David K

    VP, Chief Accounting Officer

    −$19.1K

    May 11, 2026

    1,919 sh · $9.94

  • Berkowitz Noah

    Chief Medical Officer

    −$71.4K

    Mar 18, 2026

    6,435 sh · $11.10

  • Morrison Briggs

    Director

    +$268K

    Mar 06, 2026

    20,000 sh · $13.40

  • Berkowitz Noah

    Chief Medical Officer

    −$67.6K

    Feb 13, 2026

    5,685 sh · $11.89

  • Saik Andrew

    Chief Financial Officer

    −$61K

    Feb 13, 2026

    5,134 sh · $11.89

  • Cacace Angela M

    Chief Scientific Officer

    −$54.6K

    Feb 13, 2026

    4,592 sh · $11.89

  • Teel Randy

    President and CEO · Director

    −$52.4K

    Feb 13, 2026

    4,403 sh · $11.89

  • Loomis David K

    Chief Accounting Officer

    −$12.1K

    Feb 13, 2026

    1,016 sh · $11.89

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Arvinas, Inc. company record

SEC industry classification
Pharmaceutical Preparations
Headquarters
New Haven, CT
Incorporated in
DE
Listed on
Nasdaq
SEC Central Index Key
0001655759
Previously filed as
ARVINAS HOLDING COMPANY, LLC

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought ARVN

What the stock actually did in the 90 days following each open-market purchase

Don't check ARVN — let it ping you

Get told the moment an insider moves on ARVN

Pro watches Arvinas, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add ARVN to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track ARVN on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read ARVN insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

BBIOCYTKDAWNDYNIMVTINSMIOVAITCIKYMRLEGNMDGLMRUS
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are ARVN insiders buying or selling?
Between Feb 23, 2026 and Jun 24, 2026, 7 Arvinas, Inc. insiders made 1 open-market purchase worth $268.1K and 17 sales worth $1.2M, a net sale of $903.1K. 2 of the sales were pre-scheduled under a Rule 10b5-1 plan.
How much ARVN stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 8 Arvinas, Inc. insiders made 2 open-market purchases worth $495.1K and 34 sales worth $2.3M. 2 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 2 purchases ($495.1K) and 23 sales ($1.4M). The largest purchase was Morrison Briggs buying $268K on Mar 06, 2026. The largest sale was Houston John G selling $438.6K on Feb 24, 2025.
What was the largest recent ARVN insider trade?
Morrison Briggs (Director) bought $268.1K of ARVN stock on Mar 06, 2026 at about $13.40 a share.
When did an insider last buy ARVN shares?
The most recent open-market purchase on file is Morrison Briggs (Director) buying $268.1K on Mar 06, 2026.
Where does ARVN insider trading data come from?
From the Form 4 filings Arvinas, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.